v3.26.3
Share-Based Compensation (Details) - Schedule of Summarizes Employee and Non-Employee Stock Option Activity
12 Months Ended
Jun. 30, 2026
USD ($)
shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
shares
Jun. 30, 2026
$ / shares
Schedule of Summarizes Employee and Non-Employee Stock Option Activity [Line Items]        
Number of Options, Outstanding Beginning Balance | shares 91,211      
Weighted Average Exercise Price per Share, Outstanding Beginning Balance | $ / shares   $ 88.79    
Weighted Average Remaining Contractual Term, Outstanding Ending Balance 6 years 6 months 25 days   6 years 1 month 24 days  
Aggregate Intrinsic Value, Outstanding Ending Balance | $   [1]  
Number of Options, Granted | shares 51,839      
Weighted Average Exercise Price per Share, Granted | $ / shares   8.27    
Weighted Average Remaining Contractual Term, Granted 9 years 1 month 28 days      
Aggregate Intrinsic Value, Granted | $ [1]      
Number of Options, Lapsed | shares (27,140)      
Weighted Average Exercise Price per Share, Lapsed | $ / shares   14.68    
Number of Options, Outstanding Ending Balance | shares 115,910   91,211  
Weighted Average Exercise Price per Share, Outstanding Ending Balance | $ / shares   $ 70.13    
Number of Options, Options exercisable | shares 82,455 82,455    
Weighted Average Exercise Price per Share, Options exercisable | $ / shares       $ 94.77
Weighted Average Remaining Contractual Term, Options exercisable 5 years 7 months 17 days      
Aggregate Intrinsic Value, Options exercisable | $    
[1] The aggregate intrinsic value in this table was calculated on the positive difference, if any, between the closing price per share of the Company’s common stock on June 30, 2026 of $4.37 and the per share exercise price of the underlying options.